Long-acting beta2-agonists for chronic obstructive pulmonary disease: serious adverse events

This review has been withdrawn.

The reason for withdrawal and previous versions are archived and accessible within the withdrawn record in the Cochrane Library.

Published:

15 August 2012

Authors:

Brozek J, Akl EA, Jaeschke R, Terrenato I, Cilenti V, Cazzola M, Fabbri L, O'Byrne P, Guyatt GH

Was this helpful? Donate.

If you found this evidence helpful, please consider donating to Cochrane. We are a charity that produces accessible evidence to help people make health and care decisions.
Donate
Print
PDF
Citation
Brozek J, Akl EA, Jaeschke R, Terrenato I, Cilenti V, Cazzola M, Fabbri L, O'Byrne P, Guyatt GH. Long-acting beta2-agonists for chronic obstructive pulmonary disease: serious adverse events. Cochrane Database of Systematic Reviews 2012, Issue 8. Art. No.: CD007200. DOI: 10.1002/14651858.CD007200.pub2